Key result
LCSD shows procedural success in 3 pediatric patients with treatment-refractory LQTS.
Why the study?
Does Left Cardiac Sympathetic Denervation (LCSD) improve outcomes in pediatric patients with refractory long QT syndrome?
Case Report (n=3)
No
Does Left Cardiac Sympathetic Denervation (LCSD) improve outcomes in pediatric patients with refractory long QT syndrome?
Left Cardiac Sympathetic Denervation (LCSD) can be successfully performed in pediatric patients with refractory long QT syndrome.
LCSD feasibility shown in refractory pediatric LQTS; leaves open efficacy and outcome impact.
Long QT syndrome (LQTS) is one of the leading causes of sudden cardiac death (SCD) among young people. Left Cardiac Sympathetic Denervation (LCSD) is an established procedure that has become increasingly accepted as a therapy for ventricular tachycardia (VT) in LQTS refractory to traditional treatment methods. We report the successful use of LCSD for three patients with LQTS operated in King Abdulaziz Medical City (KAMC), National Guard Health Affairs, Riyadh, Saudi Arabia.
No takes yet. Share an insight, caveat, or question.
Arwa et al. (2021) conducted a case report in Long QT syndrome (LQTS) (n=3). Left Cardiac Sympathetic Denervation (LCSD) was evaluated on Successful use of LCSD. Left Cardiac Sympathetic Denervation (LCSD) was successfully performed in 3 pediatric patients with long QT syndrome refractory to traditional treatment methods.